ARCHIVES

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

This article is from The Cancer Letter archive.

Vol. 33 No. 39 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

In Brief: Kung, Vogt, Hartwell Win general Motors Prizes; Fox Chase Hires Four Scientists; Vitetta Honored

June 14, 1991

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981